Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravitreal Aflibercept Injection for Symptomatic Macular Edema From Retinal Artery Macroaneurysms

NCT02403128 is registered in ClinicalTrials.gov with Kamal Kishore, MD as lead sponsor.

NCT NCT02403128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02403128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravitreal Aflibercept Injection for Symptomatic Macular Edema From Retinal Artery Macroaneurysms
Lead sponsor
Kamal Kishore, MD
Phase
Phase 1
Overall status
Unknown status
Start date
May 14, 2015
Completion date
February 29, 2020
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

macular edema, retinal artery macroaneurysm